Optimizing Treatment Strategies for Advanced Upper GI Cancers
Experts discuss treatment strategies for advanced upper gastrointestinal (GI) cancers, focusing on biomarker testing, treatment options, and managing adverse effects.
EP. 1: Navigating Immune-Related Adverse Events With Nivolumab in Upper GI Cancer
Experts discuss key immune-related adverse events (irAEs) to monitor in patients receiving nivolumab, how to differentiate these from disease-related symptoms, and how to manage moderate to severe irAEs, including factors that determine whether immunotherapy should be paused or discontinued.
EP. 2: Robert’s Journey With HER2-Positive Upper GI Cancer
Experts discuss Robert’s journey with HER2-positive upper gastrointestinal (GI) cancer, highlighting key treatment approaches and challenges.
EP. 3: Strategies for Managing FOLFOX Toxicity in Upper GI Cancer
Experts discuss the most common adverse events associated with the FOLFOX regimen and effective strategies for early detection and management.
EP. 4: Supporting Patients Through Treatment for Upper GI Cancer Care
Experts discuss the role of supportive therapies, such as antiemetics, nutritional support, and physical activity, in improving outcomes and patient comfort during treatment.
EP. 6: Balancing Treatment Intensity and Quality of Life in Upper GI Cancer
Experts discuss how to balance treatment intensity with maintaining quality of life, particularly in patients with advanced-stage disease.
EP. 7: Megan’s Journey With HER2-Positive Upper GI Cancer
Experts discuss Megan’s journey with HER2-positive upper gastrointestinal (GI) cancer, highlighting key treatment strategies and challenges.
Experts discuss the most common adverse events associated with trastuzumab deruxtecan, how to effectively identify and manage them to minimize treatment interruptions, and how to monitor and address interstitial lung disease (ILD), a known potential adverse effect of trastuzumab deruxtecan.
